SelfDiagnostics Overview

  • Founded
  • 2008
  • Status
  • Private
  • Employees
  • 13
  • Latest Deal Type
  • 2ndary - Private
  • Investors
  • 7

SelfDiagnostics General Information


Developer of a molecular self-diagnostic technology designed to pace up the process of treatment. The company's technology offers self-diagnostic home medical test kits, specially designed to fight against SARS Covid, helping users to understand more about their condition and obtain a better cure much faster.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Primary Industry
Other Devices and Supplies
Primary Office
  • Lauteri 5
  • Tallinn, 10114
  • Estonia
+372 623 0000

SelfDiagnostics Timeline

Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

SelfDiagnostics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Secondary Transaction - Private 01-Jan-2021 Completed Generating Revenue
3. Grant 07-Jan-2019 0000 Completed Generating Revenue
2. Grant 30-Nov-2014 $3.18M Completed Generating Revenue
1. Later Stage VC 01-Apr-2014 Completed Generating Revenue
To view SelfDiagnostics’s complete valuation and funding history, request access »

SelfDiagnostics Patents

SelfDiagnostics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3606668-A1 Lamp component distribution in a microfluid cell Pending 04-Apr-2017 0000000000
US-20200222901-A1 Lamp component distribution in a microfluid cell Pending 04-Apr-2017 0000000000
US-20150322493-A1 Method and its compositions for detection of nucleic acid target from biological samples and body fluids Abandoned 20-Oct-2012 000000000 0
US-20140114215-A1 Methods for renal neuromodulation and associated systems and devices Abandoned 20-Oct-2012 000000000 0
US-20130040296-A1 Method and rapid test device for detection of target molecule Abandoned 29-Jan-2010 C12Q1/6804 00
To view SelfDiagnostics’s complete patent history, request access »

SelfDiagnostics Executive Team (6)

Name Title Board Seat Contact Info
Marko Lehes Co-Founder, Chief Executive Officer, General Manager & Managing Partner
Harri Peiker Chief Operating Officer
Indrek Tulp Ph.D Co-Founder, Chief Technology Officer & Partner
Martin Kirsberg CFO, Member of the Management Board
Katrin Kremer Head of Laboratory Researcher
You’re viewing 5 of 6 executive team members. Get the full list »

SelfDiagnostics Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

SelfDiagnostics Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Exist Federal Ministry of Economics and Energy Government 000 0000 000000 0
Horizon 2020 SME Instrument Government 000 0000 000000 0
Pensioenfonds Archimedes Corporation 000 0000 000000 0
Zentrales Innovationsprogramm Mittelstand Other 000 0000 000000 0
Enterprise Estonia Government 000 0000 000000 0
You’re viewing 5 of 7 investors. Get the full list »